Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era
Highlights • We conducted a cross-sectional study on nasopharyngeal isolates in healthy children in the post-PCV7, initial-PCV13 era. • The most common carriage isolates, among all children, irrespective of vaccination status, were 6C, 19A and 23A. • A decrease in nasopharyngeal colonization of the...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2014-01, Vol.32 (5), p.527-534 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 534 |
|---|---|
| container_issue | 5 |
| container_start_page | 527 |
| container_title | Vaccine |
| container_volume | 32 |
| creator | Zuccotti, Gianvincenzo Mameli, Chiara Daprai, Laura Garlaschi, Maria Laura Dilillo, Dario Bedogni, Giorgio Faccini, Marino Gramegna, Maria Torresani, Erminio |
| description | Highlights • We conducted a cross-sectional study on nasopharyngeal isolates in healthy children in the post-PCV7, initial-PCV13 era. • The most common carriage isolates, among all children, irrespective of vaccination status, were 6C, 19A and 23A. • A decrease in nasopharyngeal colonization of the 6 additional PCV13 serotypes was observed in children appropriately vaccinated for age with PCV13. • Serotype 6C was the most common drug-resistant serotype. |
| doi_str_mv | 10.1016/j.vaccine.2013.12.003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1516742900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X13016976</els_id><sourcerecordid>1516742900</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-ea7c6552b98519c6cd16b76e1a5dcf5d7efc830e459f7ec73f9d5f527327474b3</originalsourceid><addsrcrecordid>eNqFkk2r1DAUhoso3vHqT1CyEdx0zEfTtBtFLn7BBRej4C6k6emdM7ZJTdKB-Wn-OzNMVXBzFyGLPO97ct5ziuI5o1tGWf36sD0aa9HBllMmtoxvKRUPig1rlCi5ZM3DYkN5XZUVo9-viicxHiilUrD2cXHFK1FxXrWb4tcOgk-nGUiPMQXsloTeEeP6fBJOaIPv0IwkLtHCnLDDERNCJH4gzkQ_7004uTvICEY_mnR52qWQaW-9tUsks4Nl8g4NkCH4iewznvYnYvc49gEcQUfSHggT5dGM4NKqOMuzsfXusNxla7L2TCCYp8WjwYwRnq33dfHtw_uvN5_K2y8fP9-8uy2trNpUglG2lpJ3bSNZa2vbs7pTNTAjezvIXsFgG0Ghku2gwCoxtL0cJFeCq0pVnbguXl185-B_LhCTnjBHMY7GgV-iZpLVquJtjv9etGqpYqpuq4zKC5rzjTHAoOeAU45SM6rPA9YHvTarzwPWjOtcIeterCWWboL-r-rPRDPwcgVMzNkNwTiL8R_X8FyeN5l7e-EgZ3dECDpaBGehxwA26d7jvV9585-DHdFhLvoDThAPfgkuD0YzHbNA787beF5GJrJnq2rxG_dr4Ro</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490717694</pqid></control><display><type>article</type><title>Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Zuccotti, Gianvincenzo ; Mameli, Chiara ; Daprai, Laura ; Garlaschi, Maria Laura ; Dilillo, Dario ; Bedogni, Giorgio ; Faccini, Marino ; Gramegna, Maria ; Torresani, Erminio</creator><creatorcontrib>Zuccotti, Gianvincenzo ; Mameli, Chiara ; Daprai, Laura ; Garlaschi, Maria Laura ; Dilillo, Dario ; Bedogni, Giorgio ; Faccini, Marino ; Gramegna, Maria ; Torresani, Erminio ; For the PneuMi Study Group (PMSG) ; PneuMi Study Group (PMSG)</creatorcontrib><description>Highlights • We conducted a cross-sectional study on nasopharyngeal isolates in healthy children in the post-PCV7, initial-PCV13 era. • The most common carriage isolates, among all children, irrespective of vaccination status, were 6C, 19A and 23A. • A decrease in nasopharyngeal colonization of the 6 additional PCV13 serotypes was observed in children appropriately vaccinated for age with PCV13. • Serotype 6C was the most common drug-resistant serotype.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2013.12.003</identifier><identifier>PMID: 24342249</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>13-Valent pneumococcal conjugate vaccine ; Allergy and Immunology ; Applied microbiology ; Bacteriology ; Biological and medical sciences ; Carrier State - microbiology ; Child, Preschool ; Children ; Cross-Sectional Studies ; Drug Resistance, Bacterial ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Infant ; Italy ; Male ; Microbial Sensitivity Tests ; Microbiology ; Miscellaneous ; Nasopharynx - microbiology ; Pneumococcal Infections - epidemiology ; Pneumococcal nasopharyngeal carriage ; Pneumococcal Vaccines - administration & dosage ; Streptococcus pneumoniae ; Streptococcus pneumoniae - classification ; Streptococcus pneumoniae - drug effects ; Streptococcus pneumoniae - isolation & purification ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><ispartof>Vaccine, 2014-01, Vol.32 (5), p.527-534</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-ea7c6552b98519c6cd16b76e1a5dcf5d7efc830e459f7ec73f9d5f527327474b3</citedby><cites>FETCH-LOGICAL-c549t-ea7c6552b98519c6cd16b76e1a5dcf5d7efc830e459f7ec73f9d5f527327474b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X13016976$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,64363,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28269428$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24342249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zuccotti, Gianvincenzo</creatorcontrib><creatorcontrib>Mameli, Chiara</creatorcontrib><creatorcontrib>Daprai, Laura</creatorcontrib><creatorcontrib>Garlaschi, Maria Laura</creatorcontrib><creatorcontrib>Dilillo, Dario</creatorcontrib><creatorcontrib>Bedogni, Giorgio</creatorcontrib><creatorcontrib>Faccini, Marino</creatorcontrib><creatorcontrib>Gramegna, Maria</creatorcontrib><creatorcontrib>Torresani, Erminio</creatorcontrib><creatorcontrib>For the PneuMi Study Group (PMSG)</creatorcontrib><creatorcontrib>PneuMi Study Group (PMSG)</creatorcontrib><title>Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights • We conducted a cross-sectional study on nasopharyngeal isolates in healthy children in the post-PCV7, initial-PCV13 era. • The most common carriage isolates, among all children, irrespective of vaccination status, were 6C, 19A and 23A. • A decrease in nasopharyngeal colonization of the 6 additional PCV13 serotypes was observed in children appropriately vaccinated for age with PCV13. • Serotype 6C was the most common drug-resistant serotype.</description><subject>13-Valent pneumococcal conjugate vaccine</subject><subject>Allergy and Immunology</subject><subject>Applied microbiology</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Carrier State - microbiology</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Cross-Sectional Studies</subject><subject>Drug Resistance, Bacterial</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Infant</subject><subject>Italy</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Nasopharynx - microbiology</subject><subject>Pneumococcal Infections - epidemiology</subject><subject>Pneumococcal nasopharyngeal carriage</subject><subject>Pneumococcal Vaccines - administration & dosage</subject><subject>Streptococcus pneumoniae</subject><subject>Streptococcus pneumoniae - classification</subject><subject>Streptococcus pneumoniae - drug effects</subject><subject>Streptococcus pneumoniae - isolation & purification</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk2r1DAUhoso3vHqT1CyEdx0zEfTtBtFLn7BBRej4C6k6emdM7ZJTdKB-Wn-OzNMVXBzFyGLPO97ct5ziuI5o1tGWf36sD0aa9HBllMmtoxvKRUPig1rlCi5ZM3DYkN5XZUVo9-viicxHiilUrD2cXHFK1FxXrWb4tcOgk-nGUiPMQXsloTeEeP6fBJOaIPv0IwkLtHCnLDDERNCJH4gzkQ_7004uTvICEY_mnR52qWQaW-9tUsks4Nl8g4NkCH4iewznvYnYvc49gEcQUfSHggT5dGM4NKqOMuzsfXusNxla7L2TCCYp8WjwYwRnq33dfHtw_uvN5_K2y8fP9-8uy2trNpUglG2lpJ3bSNZa2vbs7pTNTAjezvIXsFgG0Ghku2gwCoxtL0cJFeCq0pVnbguXl185-B_LhCTnjBHMY7GgV-iZpLVquJtjv9etGqpYqpuq4zKC5rzjTHAoOeAU45SM6rPA9YHvTarzwPWjOtcIeterCWWboL-r-rPRDPwcgVMzNkNwTiL8R_X8FyeN5l7e-EgZ3dECDpaBGehxwA26d7jvV9585-DHdFhLvoDThAPfgkuD0YzHbNA787beF5GJrJnq2rxG_dr4Ro</recordid><startdate>20140123</startdate><enddate>20140123</enddate><creator>Zuccotti, Gianvincenzo</creator><creator>Mameli, Chiara</creator><creator>Daprai, Laura</creator><creator>Garlaschi, Maria Laura</creator><creator>Dilillo, Dario</creator><creator>Bedogni, Giorgio</creator><creator>Faccini, Marino</creator><creator>Gramegna, Maria</creator><creator>Torresani, Erminio</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope></search><sort><creationdate>20140123</creationdate><title>Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era</title><author>Zuccotti, Gianvincenzo ; Mameli, Chiara ; Daprai, Laura ; Garlaschi, Maria Laura ; Dilillo, Dario ; Bedogni, Giorgio ; Faccini, Marino ; Gramegna, Maria ; Torresani, Erminio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-ea7c6552b98519c6cd16b76e1a5dcf5d7efc830e459f7ec73f9d5f527327474b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>13-Valent pneumococcal conjugate vaccine</topic><topic>Allergy and Immunology</topic><topic>Applied microbiology</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Carrier State - microbiology</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Cross-Sectional Studies</topic><topic>Drug Resistance, Bacterial</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Infant</topic><topic>Italy</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Nasopharynx - microbiology</topic><topic>Pneumococcal Infections - epidemiology</topic><topic>Pneumococcal nasopharyngeal carriage</topic><topic>Pneumococcal Vaccines - administration & dosage</topic><topic>Streptococcus pneumoniae</topic><topic>Streptococcus pneumoniae - classification</topic><topic>Streptococcus pneumoniae - drug effects</topic><topic>Streptococcus pneumoniae - isolation & purification</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zuccotti, Gianvincenzo</creatorcontrib><creatorcontrib>Mameli, Chiara</creatorcontrib><creatorcontrib>Daprai, Laura</creatorcontrib><creatorcontrib>Garlaschi, Maria Laura</creatorcontrib><creatorcontrib>Dilillo, Dario</creatorcontrib><creatorcontrib>Bedogni, Giorgio</creatorcontrib><creatorcontrib>Faccini, Marino</creatorcontrib><creatorcontrib>Gramegna, Maria</creatorcontrib><creatorcontrib>Torresani, Erminio</creatorcontrib><creatorcontrib>For the PneuMi Study Group (PMSG)</creatorcontrib><creatorcontrib>PneuMi Study Group (PMSG)</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zuccotti, Gianvincenzo</au><au>Mameli, Chiara</au><au>Daprai, Laura</au><au>Garlaschi, Maria Laura</au><au>Dilillo, Dario</au><au>Bedogni, Giorgio</au><au>Faccini, Marino</au><au>Gramegna, Maria</au><au>Torresani, Erminio</au><aucorp>For the PneuMi Study Group (PMSG)</aucorp><aucorp>PneuMi Study Group (PMSG)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2014-01-23</date><risdate>2014</risdate><volume>32</volume><issue>5</issue><spage>527</spage><epage>534</epage><pages>527-534</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Highlights • We conducted a cross-sectional study on nasopharyngeal isolates in healthy children in the post-PCV7, initial-PCV13 era. • The most common carriage isolates, among all children, irrespective of vaccination status, were 6C, 19A and 23A. • A decrease in nasopharyngeal colonization of the 6 additional PCV13 serotypes was observed in children appropriately vaccinated for age with PCV13. • Serotype 6C was the most common drug-resistant serotype.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>24342249</pmid><doi>10.1016/j.vaccine.2013.12.003</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2014-01, Vol.32 (5), p.527-534 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1516742900 |
| source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | 13-Valent pneumococcal conjugate vaccine Allergy and Immunology Applied microbiology Bacteriology Biological and medical sciences Carrier State - microbiology Child, Preschool Children Cross-Sectional Studies Drug Resistance, Bacterial Female Fundamental and applied biological sciences. Psychology Humans Infant Italy Male Microbial Sensitivity Tests Microbiology Miscellaneous Nasopharynx - microbiology Pneumococcal Infections - epidemiology Pneumococcal nasopharyngeal carriage Pneumococcal Vaccines - administration & dosage Streptococcus pneumoniae Streptococcus pneumoniae - classification Streptococcus pneumoniae - drug effects Streptococcus pneumoniae - isolation & purification Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) |
| title | Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T19%3A29%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serotype%20distribution%20and%20antimicrobial%20susceptibilities%20of%20nasopharyngeal%20isolates%20of%20Streptococcus%20pneumoniae%20from%20healthy%20children%20in%20the%2013-valent%20pneumococcal%20conjugate%20vaccine%20era&rft.jtitle=Vaccine&rft.au=Zuccotti,%20Gianvincenzo&rft.aucorp=For%20the%20PneuMi%20Study%20Group%20(PMSG)&rft.date=2014-01-23&rft.volume=32&rft.issue=5&rft.spage=527&rft.epage=534&rft.pages=527-534&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2013.12.003&rft_dat=%3Cproquest_cross%3E1516742900%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1490717694&rft_id=info:pmid/24342249&rft_els_id=1_s2_0_S0264410X13016976&rfr_iscdi=true |